KURA

Kura Oncology, Inc. NASDAQ Listed Sep 16, 2015

Healthcare ·Biotechnology ·US · kuraoncology.com

$9.56

Mkt Cap $848.6M

52w Low $5.45 58.4% of range 52w High $12.49

50d MA $8.77 200d MA $8.94

P/E (TTM) -2.8x

EV/EBITDA -2.6x

P/B 4.4x

Debt/Equity 0.1x

ROE -160.0%

P/FCF -12.9x

RSI (14) —

ATR (14) —

Beta 0.24

50d MA $8.77

200d MA $8.94

Avg Volume 1.5M

About

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genet…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 5, 2026	AMC	-0.72	-0.92	-27.8%	8.51	-2.7%	+5.3%	+10.3%	+8.8%	+8.3%	+3.9%	—
Nov 4, 2025	AMC	-0.57	-0.85	-49.1%	9.96	+0.1%	-0.2%	+2.0%	-1.0%	+3.6%	+7.3%	—
Aug 7, 2025	AMC	0.15	-0.75	-600.0%	5.96	-4.4%	-7.0%	-7.0%	+4.0%	+8.9%	+10.7%	—
May 1, 2025	AMC	-0.51	-0.66	-29.4%	6.49	-4.0%	-0.3%	+3.5%	-10.8%	-12.9%	-7.6%	—
Feb 26, 2025	AMC	-0.65	-0.22	+66.2%	7.77	+2.6%	-1.5%	-0.8%	-6.7%	-5.7%	-5.1%	—
Nov 7, 2024	AMC	-0.64	-0.63	+1.6%	17.77	-5.6%	-0.5%	-1.2%	+4.5%	-0.1%	-7.2%	—
Aug 8, 2024	AMC	-0.63	-0.59	+6.3%	19.12	+0.4%	-0.8%	-0.7%	-0.5%	-0.4%	+1.7%	—
May 2, 2024	AMC	-0.56	-0.59	-5.4%	20.59	-0.2%	+0.2%	+2.0%	+2.3%	-0.2%	+0.9%	—
Feb 27, 2024	AMC	-0.56	-0.55	+1.8%	21.76	-0.0%	-1.7%	-3.1%	-0.8%	-2.1%	-3.3%	—
Nov 2, 2023	AMC	-0.56	-0.50	+10.7%	8.42	+4.0%	+7.0%	+6.8%	+10.1%	+7.5%	+2.1%	—
Aug 3, 2023	AMC	-0.57	-0.53	+7.0%	10.54	-0.5%	+4.4%	-1.0%	-1.3%	+2.1%	+4.7%	—
May 10, 2023	AMC	-0.54	-0.50	+7.4%	11.45	-0.5%	+8.3%	+6.9%	+10.6%	+9.3%	+8.5%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 24	Mizuho	Maintains	Outperform → Outperform	—	$8.32	$8.23	-1.1%	-3.0%	+2.8%	+0.5%	-7.0%	-7.1%
Mar 13	UBS	Maintains	Buy → Buy	—	$8.84	$8.91	+0.8%	-2.1%	-1.2%	-2.9%	-5.1%	-4.6%
Mar 6	Wedbush	Maintains	Outperform → Outperform	—	$8.51	$8.28	-2.7%	+5.3%	+10.3%	+8.8%	+8.3%	+3.9%
Jan 13	Leerink Partners	Maintains	Outperform → Outperform	—	$9.17	$9.02	-1.6%	+0.4%	+2.1%	-2.8%	-7.7%	-6.2%
Jan 13	HC Wainwright & Co.	Maintains	Buy → Buy	—	$9.17	$9.02	-1.6%	+0.4%	+2.1%	-2.8%	-7.7%	-6.2%
Nov 24	Barclays	Maintains	Overweight → Overweight	—	$11.17	$11.38	+1.9%	+5.0%	+3.8%	+7.3%	+8.7%	+2.4%
Nov 14	Wedbush	Maintains	Outperform → Outperform	—	$10.68	$10.75	+0.7%	+5.0%	+1.6%	+3.7%	+6.0%	+2.8%
Nov 14	UBS	Maintains	Buy → Buy	—	$10.68	$10.75	+0.7%	+5.0%	+1.6%	+3.7%	+6.0%	+2.8%
Oct 20	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$9.84	$10.24	+4.1%	+1.5%	-2.6%	-5.7%	-7.5%	-1.4%
Oct 20	HC Wainwright & Co.	Maintains	Buy → Buy	—	$9.84	$10.24	+4.1%	+1.5%	-2.6%	-5.7%	-7.5%	-1.4%
Sep 30	HC Wainwright & Co.	Maintains	Buy → Buy	—	$8.97	$8.89	-0.9%	-1.3%	+2.6%	+1.9%	+6.7%	+9.3%
Aug 11	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$5.54	$5.55	+0.2%	+0.0%	+11.9%	+17.1%	+19.1%	+32.5%
Jun 26	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$5.80	$5.80	+0.0%	-1.2%	-2.2%	-0.5%	-3.4%	+0.2%
Jun 20	Wedbush	Maintains	Outperform → Outperform	—	$6.06	$6.11	+0.8%	-3.5%	-3.1%	-1.3%	-4.3%	-5.4%
Jun 4	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$6.42	$6.46	+0.6%	+0.5%	+2.3%	+4.8%	+4.8%	+6.1%
May 19	Mizuho	Maintains	Outperform → Outperform	—	$6.02	$5.96	-1.0%	+3.7%	+6.0%	+3.0%	+3.7%	-6.3%
May 2	Barclays	Maintains	Overweight → Overweight	—	$6.49	$6.23	-4.0%	-0.3%	+3.5%	-10.8%	-12.9%	-7.6%
Apr 29	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$6.51	$6.51	+0.0%	+0.2%	+0.8%	-0.3%	-0.6%	+3.2%
Apr 28	HC Wainwright & Co.	Maintains	Buy → Buy	—	$6.43	$6.46	+0.5%	+1.2%	+1.4%	+2.0%	+0.9%	+0.6%
Mar 6	UBS	Maintains	Buy → Buy	—	$7.37	$7.19	-2.4%	+4.5%	+2.2%	-1.8%	-0.5%	+4.6%
Feb 27	HC Wainwright & Co.	Maintains	Buy → Buy	—	$7.77	$7.97	+2.6%	-1.5%	-0.8%	-6.7%	-5.7%	-5.1%
Feb 6	Wedbush	Maintains	Outperform → Outperform	—	$9.05	$8.15	-9.9%	-2.5%	-4.4%	-2.9%	-7.8%	-7.7%
Feb 6	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$9.05	$8.15	-9.9%	-2.5%	-4.4%	-2.9%	-7.8%	-7.7%
Feb 6	HC Wainwright & Co.	Maintains	Buy → Buy	—	$9.05	$8.15	-9.9%	-2.5%	-4.4%	-2.9%	-7.8%	-7.7%
Jan 8	Scotiabank	Maintains	Sector Perform → Sector Perform	—	$8.17	$8.07	-1.2%	-4.8%	-10.4%	-11.4%	-11.1%	-11.4%
Dec 9	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$10.67	$10.76	+0.8%	-1.3%	-3.6%	-4.4%	-9.2%	-9.7%
Nov 22	BofA Securities	Maintains	Buy → Buy	—	$10.06	$10.27	+2.1%	+7.4%	+8.9%	+6.9%	+11.0%	+9.7%
Nov 21	Jefferies	Maintains	Buy → Buy	—	$15.91	$11.80	-25.8%	-36.8%	-32.1%	-31.1%	-32.4%	-29.8%
Nov 21	HC Wainwright & Co.	Maintains	Buy → Buy	—	$15.91	$11.80	-25.8%	-36.8%	-32.1%	-31.1%	-32.4%	-29.8%
Nov 19	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$16.04	$15.92	-0.7%	-0.5%	-0.8%	-37.3%	-32.7%	-31.7%
Nov 18	HC Wainwright & Co.	Maintains	Buy → Buy	—	$15.92	$15.99	+0.4%	+0.8%	+0.3%	-0.1%	-36.8%	-32.2%
Nov 13	HC Wainwright & Co.	Maintains	Buy → Buy	—	$18.57	$18.63	+0.3%	-4.4%	-11.2%	-14.3%	-13.6%	-14.1%
Nov 6	HC Wainwright & Co.	Maintains	Buy → Buy	—	$17.52	$18.04	+3.0%	+1.8%	+1.4%	+0.9%	+0.2%	+6.0%
Oct 24	HC Wainwright & Co.	Maintains	Buy → Buy	—	$17.02	$17.85	+4.9%	+4.5%	+2.9%	+4.2%	+2.0%	-0.3%
Oct 14	Stifel	Downgrade	Buy → Hold	—	$18.58	$17.98	-3.2%	-2.8%	-2.0%	-1.7%	-2.6%	-3.1%
Aug 12	HC Wainwright & Co.	Maintains	Buy → Buy	—	$18.97	$19.09	+0.6%	+0.1%	+0.3%	+0.4%	+2.5%	+1.5%
Aug 12	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$18.97	$19.09	+0.6%	+0.1%	+0.3%	+0.4%	+2.5%	+1.5%
Aug 9	Wedbush	Maintains	Outperform → Outperform	—	$19.12	$19.20	+0.4%	-0.8%	-0.7%	-0.5%	-0.4%	+1.7%
Aug 9	Stifel	Maintains	Buy → Buy	—	$19.12	$19.20	+0.4%	-0.8%	-0.7%	-0.5%	-0.4%	+1.7%
Jun 24	HC Wainwright & Co.	Maintains	Buy → Buy	—	$20.94	$21.15	+1.0%	+0.7%	-2.1%	-1.6%	-2.1%	-1.7%
Jun 18	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$20.69	$20.73	+0.2%	-4.4%	-1.8%	+1.2%	+1.9%	-1.0%
May 16	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$21.87	$21.78	-0.4%	+5.1%	+1.4%	+1.7%	+1.1%	+3.1%
May 14	HC Wainwright & Co.	Maintains	Buy → Buy	—	$20.61	$20.92	+1.5%	+1.5%	+6.1%	+11.5%	+7.6%	+7.9%
May 6	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$20.63	$20.77	+0.7%	+1.8%	+2.1%	-0.4%	+0.7%	+0.4%
May 3	HC Wainwright & Co.	Maintains	Buy → Buy	—	$20.59	$20.55	-0.2%	+0.2%	+2.0%	+2.3%	-0.2%	+0.9%
May 3	Wedbush	Maintains	Outperform → Outperform	—	$20.59	$20.55	-0.2%	+0.2%	+2.0%	+2.3%	-0.2%	+0.9%
Apr 22	HC Wainwright & Co.	Maintains	Buy → Buy	—	$17.53	$18.33	+4.6%	+3.8%	+6.8%	+7.0%	+8.4%	+12.1%
Mar 6	HC Wainwright & Co.	Maintains	Buy → Buy	—	$21.04	$21.31	+1.3%	+7.9%	+5.8%	+11.8%	+8.5%	+6.0%
Feb 28	HC Wainwright & Co.	Maintains	Buy → Buy	—	$21.76	$21.75	-0.0%	-1.7%	-3.1%	-0.8%	-2.1%	-3.3%
Feb 28	Wedbush	Maintains	Outperform → Outperform	—	$21.76	$21.75	-0.0%	-1.7%	-3.1%	-0.8%	-2.1%	-3.3%

Recent Filings

8-K

Kura Oncology, Inc. -- 8-K Filing

Kura Oncology reported 2025 financial results and provided a corporate update, likely including cash position and pipeline progress that will inform investor assessment of the company's runway and development trajectory.

Mar 5

Data updated apr 25, 2026 6:11pm · Source: massive.com